Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00301912 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn because study never opened to accrual

Conditions

Anemia
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: filgrastim
DRUG: busulfan
DRUG: fludarabine phosphate
DRUG: methotrexate
DRUG: tacrolimus
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of California, San Francisco

Collaborators

[object Object]